SMTL ID : 6n79.1

Structure of the human JAK1 kinase domain with compound 20

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.27 Å

Oligo State

monomer

Ligands

1 x KES: N-{5-[5-chloro-2-(difluoromethoxy)phenyl]-1H-pyrazol-4-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide(Non-covalent)

KES.1: 22 residues within 4Å: Chain A: L.29, G.30, E.31, G.32, G.35, K.36, V.37, A.54, V.86, M.104, E.105, F.106, L.107, G.110, S.111, E.114, R.155, N.156, L.158, G.168, D.169 Ligands: GOL.2 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.29, A:V.37, A:A.54, A:V.86, A:L.158, A:L.158, A:D.169 Hydrogen bonds: A:L.107 Water bridges: A:G.110, A:S.111, A:S.111

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: E.31, G.32, R.155, N.156, D.169 Ligands: KES.1 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.155, A:D.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zak, M. et al., Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. Bioorg.Med.Chem.Lett. (2019)

Release Date

2019-04-24

Peptides

Tyrosine-protein kinase JAK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK1

Related Entries With Identical Sequence